United Therapeutics | UTHR - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Amarin USD 182.23M 3.71M 2025-09
Ardelyx USD 83.39M 1.67M 2025-09
Baxter International USD 2.97B 805M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Insmed USD 468.87M 51.66M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
J&J USD 54.13B 3.26B 2025-12
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
Moderna USD 1.99B 306M 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
United Therapeutics USD 560.6M 14.3M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12